AP492A - 1,5 Benzodiazepine derivatives. - Google Patents

1,5 Benzodiazepine derivatives. Download PDF

Info

Publication number
AP492A
AP492A APAP/P/1994/000657A AP9400657A AP492A AP 492 A AP492 A AP 492A AP 9400657 A AP9400657 A AP 9400657A AP 492 A AP492 A AP 492A
Authority
AP
ARIPO
Prior art keywords
dioxo
benzodiazepin
ethyl
compounds
formula
Prior art date
Application number
APAP/P/1994/000657A
Other languages
English (en)
Other versions
AP9400657A0 (en
Inventor
Daniele Donati
Antonella Ursini
Mauro Corsi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of AP9400657A0 publication Critical patent/AP9400657A0/xx
Application granted granted Critical
Publication of AP492A publication Critical patent/AP492A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
APAP/P/1994/000657A 1993-07-20 1994-07-18 1,5 Benzodiazepine derivatives. AP492A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314981A GB9314981D0 (en) 1993-07-20 1993-07-20 Chemical compounds

Publications (2)

Publication Number Publication Date
AP9400657A0 AP9400657A0 (en) 1994-07-31
AP492A true AP492A (en) 1996-05-13

Family

ID=10739096

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000657A AP492A (en) 1993-07-20 1994-07-18 1,5 Benzodiazepine derivatives.

Country Status (32)

Country Link
US (1) US5716953A (no)
EP (1) EP0710230B1 (no)
JP (1) JP3587849B2 (no)
KR (1) KR100347287B1 (no)
CN (1) CN1050835C (no)
AP (1) AP492A (no)
AT (1) ATE171167T1 (no)
AU (1) AU687858B2 (no)
CA (1) CA2167308A1 (no)
CO (1) CO4290299A1 (no)
CZ (1) CZ290472B6 (no)
DE (1) DE69413405T2 (no)
DK (1) DK0710230T3 (no)
EC (1) ECSP941120A (no)
ES (1) ES2123812T3 (no)
FI (1) FI960223A (no)
GB (1) GB9314981D0 (no)
HR (1) HRP940411B1 (no)
HU (1) HU222439B1 (no)
IL (1) IL110366A (no)
IS (1) IS4190A (no)
MY (1) MY118638A (no)
NO (1) NO313288B1 (no)
NZ (1) NZ271075A (no)
PE (1) PE8295A1 (no)
PL (1) PL175609B1 (no)
RU (1) RU2135485C1 (no)
SI (1) SI0710230T1 (no)
SV (1) SV1994000031A (no)
TW (1) TW290542B (no)
WO (1) WO1995003285A1 (no)
ZA (1) ZA945238B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
TR200201026T2 (tr) 1999-10-15 2002-08-21 F.Hoffmann-La Roche Ag Benzodiazepin türevleri
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
CA2813136A1 (en) * 2004-02-27 2005-09-15 Aortx, Inc. Prosthetic heart valve delivery systems and methods
EP2137167B1 (en) * 2007-04-19 2011-08-10 F. Hoffmann-La Roche AG Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
RU2540464C2 (ru) * 2012-05-28 2015-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
RU2702359C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376849A1 (fr) * 1988-12-29 1990-07-04 Roussel-Uclaf Nouveaux dérivés de la 2,4-dioxo 2,3,4,5-tétrahydro 1H-1,5-benzodiazépine, leur procédé et les intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
EP0514133A1 (en) * 1991-05-14 1992-11-19 MERCK SHARP & DOHME LTD. Benzodiazepine derivatives, compositions containing them and their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
GB9201181D0 (en) * 1992-01-21 1992-03-11 Glaxo Spa Chemical compounds
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0376849A1 (fr) * 1988-12-29 1990-07-04 Roussel-Uclaf Nouveaux dérivés de la 2,4-dioxo 2,3,4,5-tétrahydro 1H-1,5-benzodiazépine, leur procédé et les intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
EP0514133A1 (en) * 1991-05-14 1992-11-19 MERCK SHARP & DOHME LTD. Benzodiazepine derivatives, compositions containing them and their use in therapy

Also Published As

Publication number Publication date
ATE171167T1 (de) 1998-10-15
AP9400657A0 (en) 1994-07-31
HRP940411B1 (en) 2000-12-31
US5716953A (en) 1998-02-10
DE69413405D1 (de) 1998-10-22
JPH09502428A (ja) 1997-03-11
AU7458994A (en) 1995-02-20
FI960223A0 (fi) 1996-01-17
ECSP941120A (es) 1995-01-16
PL175609B1 (pl) 1999-01-29
GB9314981D0 (en) 1993-09-01
NO313288B1 (no) 2002-09-09
HU222439B1 (hu) 2003-07-28
NZ271075A (en) 1998-06-26
DE69413405T2 (de) 1999-04-15
IL110366A (en) 1999-01-26
ES2123812T3 (es) 1999-01-16
CN1138853A (zh) 1996-12-25
ZA945238B (en) 1995-02-09
HU9600124D0 (en) 1996-03-28
TW290542B (no) 1996-11-11
EP0710230B1 (en) 1998-09-16
IL110366A0 (en) 1994-10-21
RU2135485C1 (ru) 1999-08-27
CA2167308A1 (en) 1995-02-02
KR100347287B1 (ko) 2002-12-06
PL312659A1 (en) 1996-04-29
SI0710230T1 (en) 1999-02-28
CO4290299A1 (es) 1996-04-17
PE8295A1 (es) 1995-04-20
MY118638A (en) 2004-12-31
CZ290472B6 (cs) 2002-07-17
AU687858B2 (en) 1998-03-05
DK0710230T3 (da) 1999-06-14
EP0710230A1 (en) 1996-05-08
WO1995003285A1 (en) 1995-02-02
HRP940411A2 (en) 1997-04-30
JP3587849B2 (ja) 2004-11-10
IS4190A (is) 1995-01-21
FI960223A (fi) 1996-03-19
HUT73499A (en) 1996-08-28
CN1050835C (zh) 2000-03-29
CZ17396A3 (en) 1996-07-17
NO960237D0 (no) 1996-01-19
NO960237L (no) 1996-03-19
SV1994000031A (es) 1995-10-04

Similar Documents

Publication Publication Date Title
RU2124009C1 (ru) Производные 1,5-бензодиазепина, способ их получения, фармацевтическая композиция
AP492A (en) 1,5 Benzodiazepine derivatives.
EP0538945A1 (en) Benzodiazepine derivatives, and their use as antagonists of gastrin and/or cholecystokinin
US5686449A (en) 1,5-benzodiazepines useful as gastrinor CCK-antagonists
JPH0680649A (ja) コレシストキニン拮抗剤
AU688316B2 (en) 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
US5641775A (en) 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists
US5486514A (en) Carbamate derivatives
EP0710229B1 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
WO1995003299A1 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
SI9300328A (sl) Derivati 1,5-benzodiazepina
GB2280182A (en) Benzodiazepine derivatives